ClinVar Miner

Submissions for variant NM_015512.5(DNAH1):c.5348G>T (p.Arg1783Leu)

dbSNP: rs371787188
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 3
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Invitae RCV000655831 SCV000777762 uncertain significance Spermatogenic failure 18; Ciliary dyskinesia, primary, 37 2023-05-27 criteria provided, single submitter clinical testing In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt DNAH1 protein function. ClinVar contains an entry for this variant (Variation ID: 544634). This variant has not been reported in the literature in individuals affected with DNAH1-related conditions. This variant is present in population databases (rs371787188, gnomAD 0.009%). This sequence change replaces arginine, which is basic and polar, with leucine, which is neutral and non-polar, at codon 1783 of the DNAH1 protein (p.Arg1783Leu).
Ambry Genetics RCV003343981 SCV004065972 uncertain significance Inborn genetic diseases 2023-06-16 criteria provided, single submitter clinical testing The c.5348G>T (p.R1783L) alteration is located in exon 34 (coding exon 33) of the DNAH1 gene. This alteration results from a G to T substitution at nucleotide position 5348, causing the arginine (R) at amino acid position 1783 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear.
PreventionGenetics, part of Exact Sciences RCV003424262 SCV004118457 uncertain significance DNAH1-related condition 2023-03-31 criteria provided, single submitter clinical testing The DNAH1 c.5348G>T variant is predicted to result in the amino acid substitution p.Arg1783Leu. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.012% of alleles in individuals of Latino descent in gnomAD (http://gnomad.broadinstitute.org/variant/3-52398865-G-T). Although we suspect that this variant may be benign, at this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.